Bruker Company Insiders
BRKR Stock | USD 46.56 0.59 1.28% |
Bruker's insiders are aggressively buying. The analysis of insiders' sentiment of trading Bruker stock suggests that virtually all insiders are extremely bullish at this time. Bruker employs about 11.4 K people. The company is managed by 13 executives with a total tenure of roughly 77 years, averaging almost 5.0 years of service per executive, having 876.62 employees per reported executive.
Burkhard Prause CEO President and CEO, BEST |
Frank Laukien Chairman Chairman, CEO and Pres |
Insider Sentiment 100
Aggressively Buying
Selling | Buying |
Latest Trades
2025-03-10 | Thomas Bures | Acquired 500 @ 47.4 | View | ||
2024-11-18 | Frank H Laukien | Acquired 100000 @ 50.14 | View |
Monitoring Bruker's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Bruker |
Bruker's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Bruker's future performance. Based on our forecasts, it is anticipated that Bruker will maintain a workforce of slightly above 11400 employees by April 2025.Bruker's latest congressional trading
Congressional trading in companies like Bruker, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Bruker by those in governmental positions are based on the same information available to the general public.
Bruker Management Team Effectiveness
The company has return on total asset (ROA) of 0.051 % which means that it generated a profit of $0.051 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0705 %, meaning that it created $0.0705 on every $100 dollars invested by stockholders. Bruker's management efficiency ratios could be used to measure how well Bruker manages its routine affairs as well as how well it operates its assets and liabilities. As of 03/17/2025, Return On Tangible Assets is likely to grow to 0.04. Also, Return On Capital Employed is likely to grow to 0.09. At this time, Bruker's Return On Tangible Assets are relatively stable compared to the past year. As of 03/17/2025, Intangibles To Total Assets is likely to grow to 0.44, while Total Current Assets are likely to drop slightly above 1.2 B.As of 03/17/2025, Net Income Applicable To Common Shares is likely to grow to about 358.1 M, while Common Stock Shares Outstanding is likely to drop slightly above 144.5 M.
Bruker Workforce Comparison
Bruker is rated second in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 66,307. Bruker retains roughly 11,396 in number of employees claiming about 17% of equities under Health Care industry.
Bruker Profit Margins
The company has Profit Margin (PM) of 0.03 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.17 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.17.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.52 | 0.49 |
|
| |||||
Net Profit Margin | 0.0404 | 0.0336 |
|
| |||||
Pretax Profit Margin | 0.0647 | 0.0607 |
|
| |||||
Return On Assets | 0.0333 | 0.0195 |
|
| |||||
Return On Equity | 0.096 | 0.0635 |
|
|
Bruker Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Bruker insiders, such as employees or executives, is commonly permitted as long as it does not rely on Bruker's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Bruker insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-12-01 | 1.6667 | 5 | 3 | 120,000 | 23,350 |
2024-09-01 | 0.9333 | 14 | 15 | 224,795 | 42,889 |
2024-03-01 | 1.1875 | 19 | 16 | 69,965 | 107,013 |
2023-12-01 | 1.3333 | 4 | 3 | 126,879 | 16,244 |
2023-09-01 | 1.25 | 15 | 12 | 275,014 | 176,634 |
2023-03-01 | 10.0 | 10 | 1 | 19,700 | 921.00 |
2022-12-01 | 0.6667 | 4 | 6 | 40,000 | 61,243 |
2022-09-01 | 1.6667 | 10 | 6 | 127,344 | 23,792 |
2022-03-01 | 3.6667 | 11 | 3 | 100,906 | 93,480 |
2021-12-01 | 0.5 | 3 | 6 | 37,210 | 69,663 |
2021-09-01 | 1.1053 | 21 | 19 | 473,316 | 729,794 |
2021-03-01 | 3.3333 | 10 | 3 | 21,518 | 3,836 |
2020-12-01 | 0.4286 | 3 | 7 | 11,800 | 23,722 |
2020-09-01 | 2.8 | 14 | 5 | 239,782 | 9,516 |
2020-06-01 | 1.0 | 5 | 5 | 62,500 | 32,800 |
2020-03-01 | 10.0 | 10 | 1 | 47,248 | 25,000 |
2019-12-01 | 0.625 | 5 | 8 | 36,631 | 96,402 |
2019-09-01 | 1.5833 | 19 | 12 | 307,200 | 166,102 |
2018-12-01 | 1.0 | 2 | 2 | 12,000 | 12,000 |
2018-09-01 | 4.0 | 12 | 3 | 239,102 | 7,761 |
2018-06-01 | 0.2 | 1 | 5 | 62,274 | 82,755 |
2018-03-01 | 1.5714 | 11 | 7 | 38,214 | 34,132 |
2017-12-01 | 0.6667 | 2 | 3 | 12,000 | 14,411 |
2017-09-01 | 2.5 | 10 | 4 | 318,234 | 27,126 |
2017-06-01 | 1.0 | 15 | 15 | 198,500 | 236,964 |
2017-03-01 | 5.3333 | 16 | 3 | 67,525 | 8,276 |
2016-12-01 | 3.75 | 15 | 4 | 390,030 | 40,000 |
2016-09-01 | 1.2 | 6 | 5 | 18,301 | 21,939 |
2016-06-01 | 0.7692 | 10 | 13 | 55,304 | 2,112,190 |
2016-03-01 | 2.75 | 22 | 8 | 258,217 | 165,600 |
2015-12-01 | 1.5 | 3 | 2 | 22,062 | 0.00 |
2015-09-01 | 2.5 | 10 | 4 | 269,297 | 5,116 |
2015-06-01 | 1.1111 | 10 | 9 | 1,036,051 | 1,036,736 |
2015-03-01 | 7.0 | 14 | 2 | 111,521 | 30,250 |
2014-09-01 | 7.0 | 14 | 2 | 340,413 | 13,538 |
2014-03-01 | 3.6667 | 11 | 3 | 95,150 | 5,150 |
2013-09-01 | 4.0 | 12 | 3 | 303,335 | 17,186 |
2013-06-01 | 1.5 | 6 | 4 | 153,115 | 51,575 |
2013-03-01 | 1.0 | 12 | 12 | 163,040 | 268,040 |
2012-06-01 | 1.5 | 3 | 2 | 280,000 | 25,000 |
2012-03-01 | 1.1333 | 17 | 15 | 257,575 | 266,075 |
2011-03-01 | 5.5 | 22 | 4 | 70,160 | 1,878,050 |
2010-12-01 | 0.1667 | 3 | 18 | 16,675 | 1,885,575 |
2010-09-01 | 0.3333 | 1 | 3 | 3,000 | 1,079,500 |
2010-06-01 | 1.0 | 3 | 3 | 11,000 | 11,000 |
2010-03-01 | 6.0 | 30 | 5 | 263,875 | 2,015,875 |
2009-12-01 | 1.5 | 6 | 4 | 159,570 | 2,009,000 |
2009-09-01 | 52.0 | 52 | 1 | 250,000 | 3,000,000 |
2009-06-01 | 0.5 | 1 | 2 | 100,000 | 2,100,000 |
2008-09-01 | 32.0 | 32 | 1 | 45,000 | 25,000 |
2008-06-01 | 21.25 | 85 | 4 | 526,020 | 108,020 |
2008-03-01 | 2.0 | 16 | 8 | 38,709,013 | 6,297,472 |
2007-06-01 | 14.75 | 59 | 4 | 305,000 | 50,000 |
2007-03-01 | 20.75 | 83 | 4 | 233,060 | 7,000,000 |
2005-12-01 | 1.0 | 3 | 3 | 44,100 | 44,100 |
2004-06-01 | 0.5 | 2 | 4 | 150,000 | 13,800,000 |
Bruker Notable Stakeholders
A Bruker stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Bruker often face trade-offs trying to please all of them. Bruker's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Bruker's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Burkhard Prause | President and CEO, BEST | Profile | |
Frank Laukien | Chairman, CEO and Pres | Profile | |
Falko Busse | President of the Bruker BioSpin Group and Executive Officer of the Company | Profile | |
Mark Munch | President of Bruker Nano Group | Profile | |
Juergen Srega | President of Bruker Daltonics Division and President of Bruker Calid Group | Profile | |
Gerald CPA | Executive CFO | Profile | |
Gerald Herman | Interim CFO, Principal Accounting Officer | Profile | |
Collin DSilva | Pres Division | Profile | |
Urban Faeh | Pres GmbH | Profile | |
Justin Ward | Senior Development | Profile | |
Stacey Desrochers | Treasurer Relations | Profile | |
Brent JD | General Secretary | Profile | |
Thomas Bures | Chief Officer | Profile |
About Bruker Management Performance
The success or failure of an entity such as Bruker often depends on how effective the management is. Bruker management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Bruker management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Bruker management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.03 | 0.04 | |
Return On Capital Employed | 0.06 | 0.09 | |
Return On Assets | 0.02 | 0.03 | |
Return On Equity | 0.06 | 0.10 |
Bruker Workforce Analysis
Traditionally, organizations such as Bruker use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Bruker within its industry.Bruker Manpower Efficiency
Return on Bruker Manpower
Revenue Per Employee | 295.4K | |
Revenue Per Executive | 259M | |
Net Income Per Employee | 10K | |
Net Income Per Executive | 8.8M | |
Working Capital Per Employee | 67.7K | |
Working Capital Per Executive | 59.4M |
Additional Tools for Bruker Stock Analysis
When running Bruker's price analysis, check to measure Bruker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bruker is operating at the current time. Most of Bruker's value examination focuses on studying past and present price action to predict the probability of Bruker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bruker's price. Additionally, you may evaluate how the addition of Bruker to your portfolios can decrease your overall portfolio volatility.